Published in
Springer, Clinical and Translational Oncology, 10(22), p. 1778-1785, 2020
DOI: 10.1007/s12094-020-02315-9
Links
Tools
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
Journal article published in 2020 by
E. Pérez-Ruiz 
,
J. Jiménez-Castro,
M.-A. Berciano-Guerrero ,
J. Valdivia,
S. Estalella-Mendoza,
F. Toscano,
M. Rodriguez de la Borbolla Artacho,
M. Garrido-Siles,
M. J. Martínez-Bautista,
R. Villatoro Roldan,
F. Rivas-Ruiz,
E. Nogales-Fernández,
C. Morales,
B. Pérez-Valderrama,
L. De la Cruz-Merino
and other authors.
,
J. Jiménez-Castro,
M.-A. Berciano-Guerrero ,
J. Valdivia,
S. Estalella-Mendoza,
F. Toscano,
M. Rodriguez de la Borbolla Artacho,
M. Garrido-Siles,
M. J. Martínez-Bautista,
R. Villatoro Roldan,
F. Rivas-Ruiz,
E. Nogales-Fernández,
C. Morales,
B. Pérez-Valderrama,
L. De la Cruz-Merino
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 